nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—Retinoids—Isotretinoin—peripheral nervous system neoplasm	0.114	0.363	CiPCiCtD
Acitretin—Retinoids—Tretinoin—peripheral nervous system neoplasm	0.114	0.363	CiPCiCtD
Acitretin—Isotretinoin—peripheral nervous system neoplasm	0.0981	0.363	CrCtD
Acitretin—Tretinoin—peripheral nervous system neoplasm	0.0981	0.363	CrCtD
Acitretin—Retinoids—Alitretinoin—peripheral nervous system neoplasm	0.0865	0.275	CiPCiCtD
Acitretin—Alitretinoin—peripheral nervous system neoplasm	0.0744	0.275	CrCtD
Acitretin—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.0212	0.121	CrCrCtD
Acitretin—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.0212	0.121	CrCrCtD
Acitretin—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.0212	0.121	CrCrCtD
Acitretin—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.0212	0.121	CrCrCtD
Acitretin—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.0212	0.121	CrCrCtD
Acitretin—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.0212	0.121	CrCrCtD
Acitretin—RARG—Isotretinoin—peripheral nervous system neoplasm	0.0163	0.0824	CbGbCtD
Acitretin—RXRG—Isotretinoin—peripheral nervous system neoplasm	0.0163	0.0824	CbGbCtD
Acitretin—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.0161	0.0916	CrCrCtD
Acitretin—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.0161	0.0916	CrCrCtD
Acitretin—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.0161	0.0916	CrCrCtD
Acitretin—RARB—Isotretinoin—peripheral nervous system neoplasm	0.0144	0.0729	CbGbCtD
Acitretin—RARA—Isotretinoin—peripheral nervous system neoplasm	0.0144	0.0729	CbGbCtD
Acitretin—RXRB—Isotretinoin—peripheral nervous system neoplasm	0.0144	0.0729	CbGbCtD
Acitretin—RXRA—Isotretinoin—peripheral nervous system neoplasm	0.0144	0.0729	CbGbCtD
Acitretin—RXRG—Alitretinoin—peripheral nervous system neoplasm	0.0101	0.0509	CbGbCtD
Acitretin—RARG—Alitretinoin—peripheral nervous system neoplasm	0.0101	0.0509	CbGbCtD
Acitretin—RXRG—Tretinoin—peripheral nervous system neoplasm	0.00939	0.0473	CbGbCtD
Acitretin—RARG—Tretinoin—peripheral nervous system neoplasm	0.00939	0.0473	CbGbCtD
Acitretin—RARA—Alitretinoin—peripheral nervous system neoplasm	0.00893	0.045	CbGbCtD
Acitretin—RARB—Alitretinoin—peripheral nervous system neoplasm	0.00893	0.045	CbGbCtD
Acitretin—RXRA—Alitretinoin—peripheral nervous system neoplasm	0.00893	0.045	CbGbCtD
Acitretin—RXRB—Alitretinoin—peripheral nervous system neoplasm	0.00893	0.045	CbGbCtD
Acitretin—RARB—Tretinoin—peripheral nervous system neoplasm	0.0083	0.0418	CbGbCtD
Acitretin—RXRB—Tretinoin—peripheral nervous system neoplasm	0.0083	0.0418	CbGbCtD
Acitretin—RXRA—Tretinoin—peripheral nervous system neoplasm	0.0083	0.0418	CbGbCtD
Acitretin—RARA—Tretinoin—peripheral nervous system neoplasm	0.0083	0.0418	CbGbCtD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00019	0.0771	CbGpPWpGaD
Acitretin—RXRA—ganglion—peripheral nervous system neoplasm	0.000161	0.229	CbGeAlD
Acitretin—RBP1—tongue—peripheral nervous system neoplasm	0.000154	0.22	CbGeAlD
Acitretin—RARG—tongue—peripheral nervous system neoplasm	0.000117	0.166	CbGeAlD
Acitretin—CYP26A1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000108	0.0437	CbGpPWpGaD
Acitretin—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	8.93e-05	0.0362	CbGpPWpGaD
Acitretin—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	8.01e-05	0.0325	CbGpPWpGaD
Acitretin—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	7.68e-05	0.0311	CbGpPWpGaD
Acitretin—RXRG—trigeminal ganglion—peripheral nervous system neoplasm	6.94e-05	0.0989	CbGeAlD
Acitretin—RARG—trigeminal ganglion—peripheral nervous system neoplasm	5.79e-05	0.0826	CbGeAlD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	5.01e-05	0.0203	CbGpPWpGaD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—MET—peripheral nervous system neoplasm	5e-05	0.0203	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	4.8e-05	0.0195	CbGpPWpGaD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—MET—peripheral nervous system neoplasm	4.7e-05	0.019	CbGpPWpGaD
Acitretin—RXRA—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	4.2e-05	0.017	CbGpPWpGaD
Acitretin—RBP1—Retinoic acid receptors-mediated signaling—AKT1—peripheral nervous system neoplasm	4.02e-05	0.0163	CbGpPWpGaD
Acitretin—RXRA—Orphan transporters—COX2—peripheral nervous system neoplasm	3.92e-05	0.0159	CbGpPWpGaD
Acitretin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	3.79e-05	0.0153	CbGpPWpGaD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—ERBB2—peripheral nervous system neoplasm	3.65e-05	0.0148	CbGpPWpGaD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—ERBB2—peripheral nervous system neoplasm	3.44e-05	0.0139	CbGpPWpGaD
Acitretin—RBP1—cerebellum—peripheral nervous system neoplasm	3.35e-05	0.0477	CbGeAlD
Acitretin—RARB—cerebellum—peripheral nervous system neoplasm	3.1e-05	0.0442	CbGeAlD
Acitretin—RXRA—The citric acid (TCA) cycle and respiratory electron transport—COX2—peripheral nervous system neoplasm	2.97e-05	0.012	CbGpPWpGaD
Acitretin—RXRB—cerebellum—peripheral nervous system neoplasm	2.84e-05	0.0406	CbGeAlD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—NF1—peripheral nervous system neoplasm	2.8e-05	0.0113	CbGpPWpGaD
Acitretin—RARG—Retinoic acid receptors-mediated signaling—AKT1—peripheral nervous system neoplasm	2.72e-05	0.011	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.68e-05	0.0108	CbGpPWpGaD
Acitretin—RARG—cerebellum—peripheral nervous system neoplasm	2.53e-05	0.036	CbGeAlD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	2.5e-05	0.0101	CbGpPWpGaD
Acitretin—RXRG—Retinoic acid receptors-mediated signaling—AKT1—peripheral nervous system neoplasm	2.48e-05	0.0101	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	2.47e-05	0.01	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.45e-05	0.00994	CbGpPWpGaD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—MET—peripheral nervous system neoplasm	2.45e-05	0.00992	CbGpPWpGaD
Acitretin—RARB—Retinoic acid receptors-mediated signaling—AKT1—peripheral nervous system neoplasm	2.44e-05	0.00987	CbGpPWpGaD
Acitretin—RARA—cerebellum—peripheral nervous system neoplasm	2.37e-05	0.0339	CbGeAlD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.35e-05	0.00953	CbGpPWpGaD
Acitretin—RXRB—Retinoic acid receptors-mediated signaling—AKT1—peripheral nervous system neoplasm	2.33e-05	0.00946	CbGpPWpGaD
Acitretin—RARA—Retinoic acid receptors-mediated signaling—AKT1—peripheral nervous system neoplasm	2.33e-05	0.00946	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.24e-05	0.00906	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.14e-05	0.00869	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.05e-05	0.0083	CbGpPWpGaD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—peripheral nervous system neoplasm	2.03e-05	0.00824	CbGpPWpGaD
Acitretin—RBP1—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	2.03e-05	0.00823	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	2.01e-05	0.00816	CbGpPWpGaD
Acitretin—RXRA—PPAR Alpha Pathway—MYC—peripheral nervous system neoplasm	1.97e-05	0.00797	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.96e-05	0.00796	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	1.93e-05	0.00782	CbGpPWpGaD
Acitretin—RARG—Gene Expression—EED—peripheral nervous system neoplasm	1.93e-05	0.00781	CbGpPWpGaD
Acitretin—RBP1—Disease—GNS—peripheral nervous system neoplasm	1.91e-05	0.00776	CbGpPWpGaD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—peripheral nervous system neoplasm	1.91e-05	0.00775	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.81e-05	0.00732	CbGpPWpGaD
Acitretin—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—peripheral nervous system neoplasm	1.8e-05	0.00728	CbGpPWpGaD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—ERBB2—peripheral nervous system neoplasm	1.79e-05	0.00725	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—EED—peripheral nervous system neoplasm	1.76e-05	0.00714	CbGpPWpGaD
Acitretin—RARB—Gene Expression—EED—peripheral nervous system neoplasm	1.73e-05	0.007	CbGpPWpGaD
Acitretin—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—peripheral nervous system neoplasm	1.69e-05	0.00684	CbGpPWpGaD
Acitretin—RARA—Gene Expression—EED—peripheral nervous system neoplasm	1.66e-05	0.00671	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—EED—peripheral nervous system neoplasm	1.66e-05	0.00671	CbGpPWpGaD
Acitretin—Alitretinoin—ABCB1—peripheral nervous system neoplasm	1.59e-05	1	CrCbGaD
Acitretin—RXRA—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	1.58e-05	0.0064	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—CNTN6—peripheral nervous system neoplasm	1.54e-05	0.00625	CbGpPWpGaD
Acitretin—RARG—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.54e-05	0.00624	CbGpPWpGaD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.51e-05	0.00611	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.41e-05	0.00571	CbGpPWpGaD
Acitretin—RARB—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.38e-05	0.0056	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.34e-05	0.00543	CbGpPWpGaD
Acitretin—RBP1—Disease—PPP3R1—peripheral nervous system neoplasm	1.34e-05	0.00543	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.32e-05	0.00537	CbGpPWpGaD
Acitretin—RARA—Gene Expression—SUZ12—peripheral nervous system neoplasm	1.32e-05	0.00537	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—GNS—peripheral nervous system neoplasm	1.31e-05	0.0053	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.29e-05	0.00521	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—NME1—peripheral nervous system neoplasm	1.25e-05	0.00508	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.23e-05	0.00497	CbGpPWpGaD
Acitretin—RXRA—Retinoic acid receptors-mediated signaling—AKT1—peripheral nervous system neoplasm	1.22e-05	0.00493	CbGpPWpGaD
Acitretin—RXRA—NRF2 pathway—HGF—peripheral nervous system neoplasm	1.21e-05	0.00491	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—COX2—peripheral nervous system neoplasm	1.21e-05	0.00489	CbGpPWpGaD
Acitretin—RBP1—Disease—ENO2—peripheral nervous system neoplasm	1.16e-05	0.0047	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.13e-05	0.00457	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.12e-05	0.00453	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.08e-05	0.00438	CbGpPWpGaD
Acitretin—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	1.07e-05	0.00435	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.02e-05	0.00415	CbGpPWpGaD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.02e-05	0.00415	CbGpPWpGaD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	1.02e-05	0.00414	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.02e-05	0.00412	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	1.01e-05	0.00408	CbGpPWpGaD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—peripheral nervous system neoplasm	9.96e-06	0.00404	CbGpPWpGaD
Acitretin—RXRA—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.94e-06	0.00403	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	9.81e-06	0.00397	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.56e-06	0.00387	CbGpPWpGaD
Acitretin—Headache—Tretinoin—peripheral nervous system neoplasm	9.46e-06	0.000252	CcSEcCtD
Acitretin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	9.43e-06	0.000251	CcSEcCtD
Acitretin—Constipation—Vincristine—peripheral nervous system neoplasm	9.43e-06	0.000251	CcSEcCtD
Acitretin—Pain—Vincristine—peripheral nervous system neoplasm	9.43e-06	0.000251	CcSEcCtD
Acitretin—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	9.42e-06	0.000251	CcSEcCtD
Acitretin—Diplopia—Doxorubicin—peripheral nervous system neoplasm	9.42e-06	0.000251	CcSEcCtD
Acitretin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	9.42e-06	0.000251	CcSEcCtD
Acitretin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	9.4e-06	0.00025	CcSEcCtD
Acitretin—Rash—Melphalan—peripheral nervous system neoplasm	9.39e-06	0.00025	CcSEcCtD
Acitretin—Dermatitis—Melphalan—peripheral nervous system neoplasm	9.38e-06	0.00025	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	9.38e-06	0.0038	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	9.35e-06	0.000249	CcSEcCtD
Acitretin—RBP1—Disease—SLC2A1—peripheral nervous system neoplasm	9.35e-06	0.00379	CbGpPWpGaD
Acitretin—Dry skin—Epirubicin—peripheral nervous system neoplasm	9.33e-06	0.000249	CcSEcCtD
Acitretin—Chest pain—Etoposide—peripheral nervous system neoplasm	9.31e-06	0.000248	CcSEcCtD
Acitretin—Anorexia—Cisplatin—peripheral nervous system neoplasm	9.29e-06	0.000247	CcSEcCtD
Acitretin—Migraine—Doxorubicin—peripheral nervous system neoplasm	9.27e-06	0.000247	CcSEcCtD
Acitretin—Discomfort—Etoposide—peripheral nervous system neoplasm	9.2e-06	0.000245	CcSEcCtD
Acitretin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	9.09e-06	0.000242	CcSEcCtD
Acitretin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	9.09e-06	0.000242	CcSEcCtD
Acitretin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	9.04e-06	0.000241	CcSEcCtD
Acitretin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	9.04e-06	0.000241	CcSEcCtD
Acitretin—Nausea—Topotecan—peripheral nervous system neoplasm	9.04e-06	0.000241	CcSEcCtD
Acitretin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	9.01e-06	0.00024	CcSEcCtD
Acitretin—Gastritis—Epirubicin—peripheral nervous system neoplasm	9.01e-06	0.00024	CcSEcCtD
Acitretin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	8.98e-06	0.000239	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	8.98e-06	0.000239	CcSEcCtD
Acitretin—Nausea—Tretinoin—peripheral nervous system neoplasm	8.97e-06	0.000239	CcSEcCtD
Acitretin—Nausea—Isotretinoin—peripheral nervous system neoplasm	8.97e-06	0.000239	CcSEcCtD
Acitretin—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	8.94e-06	0.00362	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	8.88e-06	0.000236	CcSEcCtD
Acitretin—Infection—Etoposide—peripheral nervous system neoplasm	8.87e-06	0.000236	CcSEcCtD
Acitretin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	8.85e-06	0.000236	CcSEcCtD
Acitretin—Nausea—Melphalan—peripheral nervous system neoplasm	8.85e-06	0.000236	CcSEcCtD
Acitretin—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	8.83e-06	0.000235	CcSEcCtD
Acitretin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—peripheral nervous system neoplasm	8.8e-06	0.00357	CbGpPWpGaD
Acitretin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	8.75e-06	0.000233	CcSEcCtD
Acitretin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	8.71e-06	0.000232	CcSEcCtD
Acitretin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	8.71e-06	0.000232	CcSEcCtD
Acitretin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	8.7e-06	0.000232	CcSEcCtD
Acitretin—Skin disorder—Etoposide—peripheral nervous system neoplasm	8.67e-06	0.000231	CcSEcCtD
Acitretin—Dry skin—Doxorubicin—peripheral nervous system neoplasm	8.64e-06	0.00023	CcSEcCtD
Acitretin—RXRA—Gene Expression—EED—peripheral nervous system neoplasm	8.63e-06	0.0035	CbGpPWpGaD
Acitretin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	8.63e-06	0.00023	CcSEcCtD
Acitretin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	8.63e-06	0.00023	CcSEcCtD
Acitretin—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	8.51e-06	0.00345	CbGpPWpGaD
Acitretin—Anorexia—Etoposide—peripheral nervous system neoplasm	8.51e-06	0.000227	CcSEcCtD
Acitretin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	8.47e-06	0.000226	CcSEcCtD
Acitretin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	8.44e-06	0.000225	CcSEcCtD
Acitretin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	8.43e-06	0.000224	CcSEcCtD
Acitretin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	8.41e-06	0.000224	CcSEcCtD
Acitretin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	8.36e-06	0.000223	CcSEcCtD
Acitretin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	8.34e-06	0.000222	CcSEcCtD
Acitretin—Pain—Cisplatin—peripheral nervous system neoplasm	8.33e-06	0.000222	CcSEcCtD
Acitretin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	8.31e-06	0.000221	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	8.31e-06	0.000221	CcSEcCtD
Acitretin—Dysuria—Epirubicin—peripheral nervous system neoplasm	8.23e-06	0.000219	CcSEcCtD
Acitretin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	8.21e-06	0.000219	CcSEcCtD
Acitretin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	8.12e-06	0.000216	CcSEcCtD
Acitretin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	8.09e-06	0.000216	CcSEcCtD
Acitretin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	8.03e-06	0.000214	CcSEcCtD
Acitretin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	8.03e-06	0.000214	CcSEcCtD
Acitretin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.02e-06	0.000214	CcSEcCtD
Acitretin—Weight increased—Epirubicin—peripheral nervous system neoplasm	8.01e-06	0.000213	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	7.99e-06	0.00324	CbGpPWpGaD
Acitretin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	7.98e-06	0.000213	CcSEcCtD
Acitretin—Weight decreased—Epirubicin—peripheral nervous system neoplasm	7.96e-06	0.000212	CcSEcCtD
Acitretin—Somnolence—Etoposide—peripheral nervous system neoplasm	7.94e-06	0.000211	CcSEcCtD
Acitretin—CYP26A1—Metabolism—ENO2—peripheral nervous system neoplasm	7.92e-06	0.00321	CbGpPWpGaD
Acitretin—Asthenia—Vincristine—peripheral nervous system neoplasm	7.91e-06	0.000211	CcSEcCtD
Acitretin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.84e-06	0.000209	CcSEcCtD
Acitretin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.83e-06	0.000208	CcSEcCtD
Acitretin—Rash—Dactinomycin—peripheral nervous system neoplasm	7.78e-06	0.000207	CcSEcCtD
Acitretin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.76e-06	0.000207	CcSEcCtD
Acitretin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	7.73e-06	0.000206	CcSEcCtD
Acitretin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	7.71e-06	0.000205	CcSEcCtD
Acitretin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.7e-06	0.000205	CcSEcCtD
Acitretin—Fatigue—Etoposide—peripheral nervous system neoplasm	7.7e-06	0.000205	CcSEcCtD
Acitretin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	7.69e-06	0.000205	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	7.66e-06	0.0031	CbGpPWpGaD
Acitretin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	7.65e-06	0.000204	CcSEcCtD
Acitretin—Jaundice—Epirubicin—peripheral nervous system neoplasm	7.65e-06	0.000204	CcSEcCtD
Acitretin—Constipation—Etoposide—peripheral nervous system neoplasm	7.64e-06	0.000203	CcSEcCtD
Acitretin—Pain—Etoposide—peripheral nervous system neoplasm	7.64e-06	0.000203	CcSEcCtD
Acitretin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	7.63e-06	0.000203	CcSEcCtD
Acitretin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	7.63e-06	0.000203	CcSEcCtD
Acitretin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	7.62e-06	0.000203	CcSEcCtD
Acitretin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.56e-06	0.000201	CcSEcCtD
Acitretin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.54e-06	0.000201	CcSEcCtD
Acitretin—RXRA—Developmental Biology—NCAM1—peripheral nervous system neoplasm	7.54e-06	0.00305	CbGpPWpGaD
Acitretin—Haematuria—Epirubicin—peripheral nervous system neoplasm	7.48e-06	0.000199	CcSEcCtD
Acitretin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	7.43e-06	0.000198	CcSEcCtD
Acitretin—Weight increased—Doxorubicin—peripheral nervous system neoplasm	7.41e-06	0.000197	CcSEcCtD
Acitretin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	7.4e-06	0.000197	CcSEcCtD
Acitretin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	7.37e-06	0.000196	CcSEcCtD
Acitretin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7.36e-06	0.000196	CcSEcCtD
Acitretin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.36e-06	0.000196	CcSEcCtD
Acitretin—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.33e-06	0.000195	CcSEcCtD
Acitretin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.3e-06	0.000194	CcSEcCtD
Acitretin—Dizziness—Vincristine—peripheral nervous system neoplasm	7.29e-06	0.000194	CcSEcCtD
Acitretin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.27e-06	0.000194	CcSEcCtD
Acitretin—Rash—Alitretinoin—peripheral nervous system neoplasm	7.21e-06	0.000192	CcSEcCtD
Acitretin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	7.21e-06	0.000192	CcSEcCtD
Acitretin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	7.18e-06	0.000191	CcSEcCtD
Acitretin—Headache—Alitretinoin—peripheral nervous system neoplasm	7.17e-06	0.000191	CcSEcCtD
Acitretin—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.12e-06	0.00019	CcSEcCtD
Acitretin—Urticaria—Etoposide—peripheral nervous system neoplasm	7.09e-06	0.000189	CcSEcCtD
Acitretin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	7.08e-06	0.000189	CcSEcCtD
Acitretin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	7.08e-06	0.000188	CcSEcCtD
Acitretin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	7.08e-06	0.000188	CcSEcCtD
Acitretin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	7.06e-06	0.000188	CcSEcCtD
Acitretin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.06e-06	0.000188	CcSEcCtD
Acitretin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.06e-06	0.000188	CcSEcCtD
Acitretin—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	7.06e-06	0.000188	CcSEcCtD
Acitretin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	7.06e-06	0.000188	CcSEcCtD
Acitretin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	7.04e-06	0.000188	CcSEcCtD
Acitretin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	7.04e-06	0.000188	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.04e-06	0.00285	CbGpPWpGaD
Acitretin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	7.01e-06	0.000187	CcSEcCtD
Acitretin—Vomiting—Vincristine—peripheral nervous system neoplasm	7.01e-06	0.000187	CcSEcCtD
Acitretin—Asthenia—Cisplatin—peripheral nervous system neoplasm	6.99e-06	0.000186	CcSEcCtD
Acitretin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	6.99e-06	0.000186	CcSEcCtD
Acitretin—Rash—Vincristine—peripheral nervous system neoplasm	6.95e-06	0.000185	CcSEcCtD
Acitretin—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.94e-06	0.000185	CcSEcCtD
Acitretin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	6.94e-06	0.000185	CcSEcCtD
Acitretin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	6.92e-06	0.000184	CcSEcCtD
Acitretin—Headache—Vincristine—peripheral nervous system neoplasm	6.91e-06	0.000184	CcSEcCtD
Acitretin—RXRA—Gene Expression—SUZ12—peripheral nervous system neoplasm	6.9e-06	0.0028	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.87e-06	0.00279	CbGpPWpGaD
Acitretin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	6.85e-06	0.000182	CcSEcCtD
Acitretin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	6.81e-06	0.000181	CcSEcCtD
Acitretin—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.79e-06	0.000181	CcSEcCtD
Acitretin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	6.79e-06	0.000181	CcSEcCtD
Acitretin—RXRA—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.71e-06	0.00272	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—BCHE—peripheral nervous system neoplasm	6.69e-06	0.00271	CbGpPWpGaD
Acitretin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.67e-06	0.000178	CcSEcCtD
Acitretin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	6.58e-06	0.000175	CcSEcCtD
Acitretin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.58e-06	0.000175	CcSEcCtD
Acitretin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	6.57e-06	0.000175	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.56e-06	0.00266	CbGpPWpGaD
Acitretin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	6.55e-06	0.000174	CcSEcCtD
Acitretin—Nausea—Vincristine—peripheral nervous system neoplasm	6.55e-06	0.000174	CcSEcCtD
Acitretin—Flushing—Epirubicin—peripheral nervous system neoplasm	6.54e-06	0.000174	CcSEcCtD
Acitretin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	6.53e-06	0.000174	CcSEcCtD
Acitretin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	6.52e-06	0.000174	CcSEcCtD
Acitretin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	6.52e-06	0.000174	CcSEcCtD
Acitretin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	6.49e-06	0.000173	CcSEcCtD
Acitretin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.47e-06	0.000172	CcSEcCtD
Acitretin—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	6.42e-06	0.000171	CcSEcCtD
Acitretin—Asthenia—Etoposide—peripheral nervous system neoplasm	6.41e-06	0.000171	CcSEcCtD
Acitretin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.39e-06	0.00017	CcSEcCtD
Acitretin—CYP26A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.38e-06	0.00259	CbGpPWpGaD
Acitretin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.36e-06	0.000169	CcSEcCtD
Acitretin—Chills—Epirubicin—peripheral nervous system neoplasm	6.32e-06	0.000168	CcSEcCtD
Acitretin—Pruritus—Etoposide—peripheral nervous system neoplasm	6.32e-06	0.000168	CcSEcCtD
Acitretin—CYP26A1—Metabolism—TH—peripheral nervous system neoplasm	6.29e-06	0.00255	CbGpPWpGaD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.29e-06	0.00255	CbGpPWpGaD
Acitretin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	6.28e-06	0.000167	CcSEcCtD
Acitretin—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.23e-06	0.000166	CcSEcCtD
Acitretin—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.2e-06	0.000165	CcSEcCtD
Acitretin—Rash—Cisplatin—peripheral nervous system neoplasm	6.15e-06	0.000164	CcSEcCtD
Acitretin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	6.14e-06	0.000164	CcSEcCtD
Acitretin—Erythema—Epirubicin—peripheral nervous system neoplasm	6.13e-06	0.000163	CcSEcCtD
Acitretin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.11e-06	0.000163	CcSEcCtD
Acitretin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	6.09e-06	0.000162	CcSEcCtD
Acitretin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.08e-06	0.000162	CcSEcCtD
Acitretin—Flushing—Doxorubicin—peripheral nervous system neoplasm	6.05e-06	0.000161	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.02e-06	0.00244	CbGpPWpGaD
Acitretin—Tension—Epirubicin—peripheral nervous system neoplasm	6.02e-06	0.00016	CcSEcCtD
Acitretin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.01e-06	0.00016	CcSEcCtD
Acitretin—Nervousness—Epirubicin—peripheral nervous system neoplasm	5.96e-06	0.000159	CcSEcCtD
Acitretin—Back pain—Epirubicin—peripheral nervous system neoplasm	5.93e-06	0.000158	CcSEcCtD
Acitretin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	5.91e-06	0.000157	CcSEcCtD
Acitretin—Dizziness—Etoposide—peripheral nervous system neoplasm	5.9e-06	0.000157	CcSEcCtD
Acitretin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	5.9e-06	0.000157	CcSEcCtD
Acitretin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	5.89e-06	0.000157	CcSEcCtD
Acitretin—Chills—Doxorubicin—peripheral nervous system neoplasm	5.85e-06	0.000156	CcSEcCtD
Acitretin—Nausea—Cisplatin—peripheral nervous system neoplasm	5.79e-06	0.000154	CcSEcCtD
Acitretin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	5.78e-06	0.000154	CcSEcCtD
Acitretin—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.76e-06	0.000153	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.74e-06	0.00233	CbGpPWpGaD
Acitretin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.69e-06	0.000152	CcSEcCtD
Acitretin—Vomiting—Etoposide—peripheral nervous system neoplasm	5.68e-06	0.000151	CcSEcCtD
Acitretin—Erythema—Doxorubicin—peripheral nervous system neoplasm	5.67e-06	0.000151	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	5.63e-06	0.00228	CbGpPWpGaD
Acitretin—Rash—Etoposide—peripheral nervous system neoplasm	5.63e-06	0.00015	CcSEcCtD
Acitretin—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.62e-06	0.00015	CcSEcCtD
Acitretin—Headache—Etoposide—peripheral nervous system neoplasm	5.59e-06	0.000149	CcSEcCtD
Acitretin—RXRA—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.58e-06	0.00226	CbGpPWpGaD
Acitretin—Tension—Doxorubicin—peripheral nervous system neoplasm	5.57e-06	0.000148	CcSEcCtD
Acitretin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.56e-06	0.000148	CcSEcCtD
Acitretin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.54e-06	0.00224	CbGpPWpGaD
Acitretin—Malaise—Epirubicin—peripheral nervous system neoplasm	5.53e-06	0.000147	CcSEcCtD
Acitretin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.51e-06	0.000147	CcSEcCtD
Acitretin—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.49e-06	0.000146	CcSEcCtD
Acitretin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.46e-06	0.000145	CcSEcCtD
Acitretin—Cough—Epirubicin—peripheral nervous system neoplasm	5.35e-06	0.000143	CcSEcCtD
Acitretin—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	5.35e-06	0.000142	CcSEcCtD
Acitretin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.31e-06	0.00215	CbGpPWpGaD
Acitretin—Nausea—Etoposide—peripheral nervous system neoplasm	5.3e-06	0.000141	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.27e-06	0.00213	CbGpPWpGaD
Acitretin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.26e-06	0.00014	CcSEcCtD
Acitretin—RBP1—Disease—PTPN11—peripheral nervous system neoplasm	5.23e-06	0.00212	CbGpPWpGaD
Acitretin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.22e-06	0.000139	CcSEcCtD
Acitretin—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.22e-06	0.000139	CcSEcCtD
Acitretin—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.22e-06	0.000139	CcSEcCtD
Acitretin—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.2e-06	0.000139	CcSEcCtD
Acitretin—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.16e-06	0.000137	CcSEcCtD
Acitretin—CYP26A1—Metabolism—GNAS—peripheral nervous system neoplasm	5.14e-06	0.00208	CbGpPWpGaD
Acitretin—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.12e-06	0.000136	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.11e-06	0.00207	CbGpPWpGaD
Acitretin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.11e-06	0.000136	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.06e-06	0.00205	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.04e-06	0.00204	CbGpPWpGaD
Acitretin—Oedema—Epirubicin—peripheral nervous system neoplasm	5.01e-06	0.000133	CcSEcCtD
Acitretin—Infection—Epirubicin—peripheral nervous system neoplasm	4.97e-06	0.000132	CcSEcCtD
Acitretin—Cough—Doxorubicin—peripheral nervous system neoplasm	4.95e-06	0.000132	CcSEcCtD
Acitretin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.86e-06	0.000129	CcSEcCtD
Acitretin—RXRA—Metabolism—GNS—peripheral nervous system neoplasm	4.85e-06	0.00197	CbGpPWpGaD
Acitretin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.84e-06	0.000129	CcSEcCtD
Acitretin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.83e-06	0.000129	CcSEcCtD
Acitretin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.83e-06	0.000129	CcSEcCtD
Acitretin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.83e-06	0.000129	CcSEcCtD
Acitretin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.81e-06	0.000128	CcSEcCtD
Acitretin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.77e-06	0.000127	CcSEcCtD
Acitretin—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.77e-06	0.000127	CcSEcCtD
Acitretin—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	4.76e-06	0.00193	CbGpPWpGaD
Acitretin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.72e-06	0.000126	CcSEcCtD
Acitretin—RXRA—Metabolism—NME1—peripheral nervous system neoplasm	4.65e-06	0.00189	CbGpPWpGaD
Acitretin—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.63e-06	0.000123	CcSEcCtD
Acitretin—Infection—Doxorubicin—peripheral nervous system neoplasm	4.6e-06	0.000123	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.56e-06	0.000121	CcSEcCtD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	4.54e-06	0.00184	CbGpPWpGaD
Acitretin—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.53e-06	0.00184	CbGpPWpGaD
Acitretin—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.53e-06	0.000121	CcSEcCtD
Acitretin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.5e-06	0.00012	CcSEcCtD
Acitretin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.49e-06	0.00012	CcSEcCtD
Acitretin—RXRA—Metabolism—COX2—peripheral nervous system neoplasm	4.48e-06	0.00181	CbGpPWpGaD
Acitretin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.48e-06	0.000119	CcSEcCtD
Acitretin—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.45e-06	0.000118	CcSEcCtD
Acitretin—RARG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.42e-06	0.00179	CbGpPWpGaD
Acitretin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.41e-06	0.000118	CcSEcCtD
Acitretin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.41e-06	0.000117	CcSEcCtD
Acitretin—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.36e-06	0.00177	CbGpPWpGaD
Acitretin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.35e-06	0.000116	CcSEcCtD
Acitretin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.32e-06	0.000115	CcSEcCtD
Acitretin—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.32e-06	0.000115	CcSEcCtD
Acitretin—Constipation—Epirubicin—peripheral nervous system neoplasm	4.28e-06	0.000114	CcSEcCtD
Acitretin—Pain—Epirubicin—peripheral nervous system neoplasm	4.28e-06	0.000114	CcSEcCtD
Acitretin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.22e-06	0.000112	CcSEcCtD
Acitretin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.19e-06	0.000112	CcSEcCtD
Acitretin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.16e-06	0.000111	CcSEcCtD
Acitretin—RBP1—Disease—ERBB2—peripheral nervous system neoplasm	4.13e-06	0.00167	CbGpPWpGaD
Acitretin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.12e-06	0.00011	CcSEcCtD
Acitretin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.12e-06	0.00011	CcSEcCtD
Acitretin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.09e-06	0.000109	CcSEcCtD
Acitretin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	4.09e-06	0.00166	CbGpPWpGaD
Acitretin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.08e-06	0.000109	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.07e-06	0.00165	CbGpPWpGaD
Acitretin—RXRG—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.05e-06	0.00164	CbGpPWpGaD
Acitretin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.03e-06	0.000107	CcSEcCtD
Acitretin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4e-06	0.000106	CcSEcCtD
Acitretin—RXRA—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4e-06	0.00162	CbGpPWpGaD
Acitretin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.99e-06	0.000106	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	3.99e-06	0.00162	CbGpPWpGaD
Acitretin—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.98e-06	0.000106	CcSEcCtD
Acitretin—RARB—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	3.97e-06	0.00161	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	3.96e-06	0.00161	CbGpPWpGaD
Acitretin—Pain—Doxorubicin—peripheral nervous system neoplasm	3.96e-06	0.000105	CcSEcCtD
Acitretin—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.96e-06	0.000105	CcSEcCtD
Acitretin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.96e-06	0.000105	CcSEcCtD
Acitretin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.96e-06	0.000105	CcSEcCtD
Acitretin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.82e-06	0.000102	CcSEcCtD
Acitretin—RARA—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	3.8e-06	0.00154	CbGpPWpGaD
Acitretin—RXRB—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	3.8e-06	0.00154	CbGpPWpGaD
Acitretin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.79e-06	0.000101	CcSEcCtD
Acitretin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.69e-06	9.82e-05	CcSEcCtD
Acitretin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.68e-06	9.8e-05	CcSEcCtD
Acitretin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.66e-06	9.75e-05	CcSEcCtD
Acitretin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.66e-06	9.75e-05	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.66e-06	0.00148	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—MET—peripheral nervous system neoplasm	3.6e-06	0.00146	CbGpPWpGaD
Acitretin—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.59e-06	9.56e-05	CcSEcCtD
Acitretin—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.54e-06	9.43e-05	CcSEcCtD
Acitretin—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	3.5e-06	0.00142	CbGpPWpGaD
Acitretin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.42e-06	9.12e-05	CcSEcCtD
Acitretin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.41e-06	9.09e-05	CcSEcCtD
Acitretin—RXRA—Developmental Biology—PTPN11—peripheral nervous system neoplasm	3.33e-06	0.00135	CbGpPWpGaD
Acitretin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.32e-06	8.85e-05	CcSEcCtD
Acitretin—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.31e-06	8.81e-05	CcSEcCtD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.28e-06	0.00133	CbGpPWpGaD
Acitretin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.28e-06	8.73e-05	CcSEcCtD
Acitretin—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.18e-06	8.47e-05	CcSEcCtD
Acitretin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.17e-06	8.44e-05	CcSEcCtD
Acitretin—Rash—Epirubicin—peripheral nervous system neoplasm	3.16e-06	8.4e-05	CcSEcCtD
Acitretin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.15e-06	8.4e-05	CcSEcCtD
Acitretin—RBP1—Disease—NRAS—peripheral nervous system neoplasm	3.14e-06	0.00127	CbGpPWpGaD
Acitretin—Headache—Epirubicin—peripheral nervous system neoplasm	3.14e-06	8.35e-05	CcSEcCtD
Acitretin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.06e-06	8.16e-05	CcSEcCtD
Acitretin—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.06e-06	0.00124	CbGpPWpGaD
Acitretin—Nausea—Epirubicin—peripheral nervous system neoplasm	2.97e-06	7.92e-05	CcSEcCtD
Acitretin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.94e-06	7.84e-05	CcSEcCtD
Acitretin—RXRA—Metabolism—ENO2—peripheral nervous system neoplasm	2.94e-06	0.00119	CbGpPWpGaD
Acitretin—RBP1—Disease—MYC—peripheral nervous system neoplasm	2.93e-06	0.00119	CbGpPWpGaD
Acitretin—Rash—Doxorubicin—peripheral nervous system neoplasm	2.92e-06	7.78e-05	CcSEcCtD
Acitretin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.92e-06	7.77e-05	CcSEcCtD
Acitretin—Headache—Doxorubicin—peripheral nervous system neoplasm	2.9e-06	7.73e-05	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.89e-06	0.00117	CbGpPWpGaD
Acitretin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.77e-06	0.00112	CbGpPWpGaD
Acitretin—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.75e-06	7.33e-05	CcSEcCtD
Acitretin—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.65e-06	0.00107	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.63e-06	0.00107	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.63e-06	0.00106	CbGpPWpGaD
Acitretin—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.54e-06	0.00103	CbGpPWpGaD
Acitretin—RXRA—Metabolism—BCHE—peripheral nervous system neoplasm	2.48e-06	0.00101	CbGpPWpGaD
Acitretin—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	2.45e-06	0.000994	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.37e-06	0.00096	CbGpPWpGaD
Acitretin—RXRA—Metabolism—TH—peripheral nervous system neoplasm	2.34e-06	0.000947	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.31e-06	0.000935	CbGpPWpGaD
Acitretin—RBP1—Disease—HRAS—peripheral nervous system neoplasm	2.3e-06	0.000932	CbGpPWpGaD
Acitretin—ALB—Metabolism—GNS—peripheral nervous system neoplasm	2.21e-06	0.000897	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.2e-06	0.000892	CbGpPWpGaD
Acitretin—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	2.15e-06	0.000869	CbGpPWpGaD
Acitretin—RARG—Gene Expression—MYC—peripheral nervous system neoplasm	2.13e-06	0.000863	CbGpPWpGaD
Acitretin—ALB—Metabolism—NME1—peripheral nervous system neoplasm	2.12e-06	0.00086	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.05e-06	0.000831	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	2.04e-06	0.000828	CbGpPWpGaD
Acitretin—ALB—Metabolism—COX2—peripheral nervous system neoplasm	2.04e-06	0.000828	CbGpPWpGaD
Acitretin—RBP1—Disease—AKT1—peripheral nervous system neoplasm	2.03e-06	0.000823	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—NRAS—peripheral nervous system neoplasm	2e-06	0.000812	CbGpPWpGaD
Acitretin—RXRA—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.98e-06	0.000803	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—MYC—peripheral nervous system neoplasm	1.95e-06	0.000789	CbGpPWpGaD
Acitretin—RARB—Gene Expression—MYC—peripheral nervous system neoplasm	1.91e-06	0.000774	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GNAS—peripheral nervous system neoplasm	1.91e-06	0.000773	CbGpPWpGaD
Acitretin—RXRA—Metabolism—ABCB1—peripheral nervous system neoplasm	1.87e-06	0.000758	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.86e-06	0.000752	CbGpPWpGaD
Acitretin—RARA—Gene Expression—MYC—peripheral nervous system neoplasm	1.83e-06	0.000742	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—MYC—peripheral nervous system neoplasm	1.83e-06	0.000742	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.82e-06	0.000738	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.68e-06	0.000682	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.61e-06	0.000652	CbGpPWpGaD
Acitretin—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.49e-06	0.000604	CbGpPWpGaD
Acitretin—RARG—Gene Expression—AKT1—peripheral nervous system neoplasm	1.48e-06	0.000599	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.47e-06	0.000594	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.42e-06	0.000576	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.39e-06	0.000562	CbGpPWpGaD
Acitretin—RXRG—Gene Expression—AKT1—peripheral nervous system neoplasm	1.35e-06	0.000547	CbGpPWpGaD
Acitretin—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	1.34e-06	0.000543	CbGpPWpGaD
Acitretin—RARB—Gene Expression—AKT1—peripheral nervous system neoplasm	1.32e-06	0.000537	CbGpPWpGaD
Acitretin—RXRA—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.29e-06	0.000524	CbGpPWpGaD
Acitretin—RARA—Gene Expression—AKT1—peripheral nervous system neoplasm	1.27e-06	0.000515	CbGpPWpGaD
Acitretin—RXRB—Gene Expression—AKT1—peripheral nervous system neoplasm	1.27e-06	0.000515	CbGpPWpGaD
Acitretin—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	1.13e-06	0.000459	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.12e-06	0.000455	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.08e-06	0.000438	CbGpPWpGaD
Acitretin—ALB—Metabolism—TH—peripheral nervous system neoplasm	1.07e-06	0.000432	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—MYC—peripheral nervous system neoplasm	9.55e-07	0.000387	CbGpPWpGaD
Acitretin—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	8.96e-07	0.000363	CbGpPWpGaD
Acitretin—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	8.7e-07	0.000352	CbGpPWpGaD
Acitretin—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	8.53e-07	0.000346	CbGpPWpGaD
Acitretin—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	6.86e-07	0.000278	CbGpPWpGaD
Acitretin—RXRA—Gene Expression—AKT1—peripheral nervous system neoplasm	6.62e-07	0.000268	CbGpPWpGaD
Acitretin—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	6.56e-07	0.000266	CbGpPWpGaD
Acitretin—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	5.79e-07	0.000235	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AKT1—peripheral nervous system neoplasm	5.15e-07	0.000209	CbGpPWpGaD
Acitretin—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	2.35e-07	9.51e-05	CbGpPWpGaD
